For Treatment of Chronic Hepatitis B Virus Infection
Infectious Diseases
2
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
Vir BiotechnologyBRII-179
Clinical Trials (1)
Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)
Start: Aug 2024Est. completion: Jun 2027
Phase 2Active Not Recruiting
Related Jobs in Infectious Diseases
Senior Recruiter
Invivyd
New Haven, CT (Northeast preferred)
5h ago
$120K - $160K/yr
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
12h ago
$179K - $237K/yr
Technician, Operations, DSP/ Technicien(ne) des opérations, DSP
Verona Pharma
CAN - Prince Edward Island - Charlottetown
Yesterday
$47K - $79K/yr
HVAC Maintenance Technician
Verona Pharma
USA - Delaware - Millsboro (Intervet)
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space